Daily Cashew and Brazil Nut Consumption Modifies Intestinal Health in Overweight Women on Energy-Restricted Intervention : A Randomized Controlled Trial (Brazilian Nuts Study)
Copyright © 2024 American Society for Nutrition. Published by Elsevier Inc. All rights reserved..
BACKGROUND: Increased intestinal permeability and dysbiosis are related to obesity. Nuts can provide nutrients and bioactive compounds that modulate gut microbiota and inflammation, enhancing the beneficial effects of weight loss.
OBJECTIVES: To evaluate the effect of consuming cashew nuts (Anacardium occidentale L.) and Brazil nuts (Bertholletia excelsa H.B.K) on intestinal permeability and microbiota, fecal SCFAs and pH, inflammation, and weight loss in energy restriction condition.
METHODS: In this 8-week randomized controlled trial, 40 women with overweight or obesity were assigned to energy-restricted groups (-500 kcal/d): control group (free of nuts) or Brazilian nuts group (BN: 30 g of cashew nuts and 15 g of Brazil nuts per day). Permeability was analyzed by the lactulose/mannitol test and the microbiota by sequencing the 16S gene in the V3-V4 regions. Plasma concentrations of inflammatory cytokines (TNF, IL-6, IL-10, IL-8, IL-17A) and C-reactive protein were analyzed.
RESULTS: In total, 25 women completed the intervention. Both groups lost weight without statistical differences. Lactulose excretion increased only in the control group (P < 0.05). The BN consumption increased fecal propionic acid and potentially beneficial bacteria, such as Ruminococcus, Roseburia, strains NK4A214 and UCG-002 from the Ruminococcaceae family, but also Lachnospiraceae family, Bacteroides, and Lachnoclostridium, when compared to the control group. Changes in intestinal permeability were correlated to a greater reduction in body fat (kg), and IL-8, and increases in Ruminococcus abundance.
CONCLUSION: Our findings demonstrate a positive impact of BN consumption within an energy-restricted context, linked to the augmentation of potentially beneficial bacteria and pathways associated with body fat reduction. Besides, BN consumption mitigated increased intestinal permeability, although its capacity to diminish permeability or enhance weight loss proved limited. This trial was registered at the Brazilian Registry of Clinical Trials as ReBEC (ID: RBR-3ntxrm).
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2024 |
---|---|
Erschienen: |
2024 |
Enthalten in: |
Zur Gesamtaufnahme - volume:154 |
---|---|
Enthalten in: |
The Journal of nutrition - 154(2024), 3 vom: 11. März, Seite 962-977 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Kelly Souza Silveira, Brenda [VerfasserIn] |
---|
Links: |
---|
Themen: |
4618-18-2 |
---|
Anmerkungen: |
Date Completed 11.03.2024 Date Revised 11.03.2024 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1016/j.tjnut.2023.12.022 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM36736848X |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM36736848X | ||
003 | DE-627 | ||
005 | 20240311232131.0 | ||
007 | cr uuu---uuuuu | ||
008 | 240122s2024 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.tjnut.2023.12.022 |2 doi | |
028 | 5 | 2 | |a pubmed24n1323.xml |
035 | |a (DE-627)NLM36736848X | ||
035 | |a (NLM)38246355 | ||
035 | |a (PII)S0022-3166(23)72811-3 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Kelly Souza Silveira, Brenda |e verfasserin |4 aut | |
245 | 1 | 0 | |a Daily Cashew and Brazil Nut Consumption Modifies Intestinal Health in Overweight Women on Energy-Restricted Intervention |b A Randomized Controlled Trial (Brazilian Nuts Study) |
264 | 1 | |c 2024 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 11.03.2024 | ||
500 | |a Date Revised 11.03.2024 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Copyright © 2024 American Society for Nutrition. Published by Elsevier Inc. All rights reserved. | ||
520 | |a BACKGROUND: Increased intestinal permeability and dysbiosis are related to obesity. Nuts can provide nutrients and bioactive compounds that modulate gut microbiota and inflammation, enhancing the beneficial effects of weight loss | ||
520 | |a OBJECTIVES: To evaluate the effect of consuming cashew nuts (Anacardium occidentale L.) and Brazil nuts (Bertholletia excelsa H.B.K) on intestinal permeability and microbiota, fecal SCFAs and pH, inflammation, and weight loss in energy restriction condition | ||
520 | |a METHODS: In this 8-week randomized controlled trial, 40 women with overweight or obesity were assigned to energy-restricted groups (-500 kcal/d): control group (free of nuts) or Brazilian nuts group (BN: 30 g of cashew nuts and 15 g of Brazil nuts per day). Permeability was analyzed by the lactulose/mannitol test and the microbiota by sequencing the 16S gene in the V3-V4 regions. Plasma concentrations of inflammatory cytokines (TNF, IL-6, IL-10, IL-8, IL-17A) and C-reactive protein were analyzed | ||
520 | |a RESULTS: In total, 25 women completed the intervention. Both groups lost weight without statistical differences. Lactulose excretion increased only in the control group (P < 0.05). The BN consumption increased fecal propionic acid and potentially beneficial bacteria, such as Ruminococcus, Roseburia, strains NK4A214 and UCG-002 from the Ruminococcaceae family, but also Lachnospiraceae family, Bacteroides, and Lachnoclostridium, when compared to the control group. Changes in intestinal permeability were correlated to a greater reduction in body fat (kg), and IL-8, and increases in Ruminococcus abundance | ||
520 | |a CONCLUSION: Our findings demonstrate a positive impact of BN consumption within an energy-restricted context, linked to the augmentation of potentially beneficial bacteria and pathways associated with body fat reduction. Besides, BN consumption mitigated increased intestinal permeability, although its capacity to diminish permeability or enhance weight loss proved limited. This trial was registered at the Brazilian Registry of Clinical Trials as ReBEC (ID: RBR-3ntxrm) | ||
650 | 4 | |a Randomized Controlled Trial | |
650 | 4 | |a Journal Article | |
650 | 4 | |a dysbiosis | |
650 | 4 | |a inflammation | |
650 | 4 | |a obesity | |
650 | 4 | |a selenium | |
650 | 4 | |a short-chain fatty acids | |
650 | 7 | |a Interleukin-8 |2 NLM | |
650 | 7 | |a Lactulose |2 NLM | |
650 | 7 | |a 4618-18-2 |2 NLM | |
700 | 1 | |a Mayumi Usuda Prado Rocha, Daniela |e verfasserin |4 aut | |
700 | 1 | |a Stampini Duarte Martino, Hércia |e verfasserin |4 aut | |
700 | 1 | |a Grancieri, Mariana |e verfasserin |4 aut | |
700 | 1 | |a Juste Contin Gomes, Mariana |e verfasserin |4 aut | |
700 | 1 | |a Cuquetto Mantovani, Hilário |e verfasserin |4 aut | |
700 | 1 | |a Bressan, Josefina |e verfasserin |4 aut | |
700 | 1 | |a Hermana Miranda Hermsdorff, Helen |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t The Journal of nutrition |d 1945 |g 154(2024), 3 vom: 11. März, Seite 962-977 |w (DE-627)NLM000006300 |x 1541-6100 |7 nnns |
773 | 1 | 8 | |g volume:154 |g year:2024 |g number:3 |g day:11 |g month:03 |g pages:962-977 |
856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.tjnut.2023.12.022 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 154 |j 2024 |e 3 |b 11 |c 03 |h 962-977 |